Bivigam
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $606,245 | 739 | 14 |
| 2022 | $562,107 | 591 | 3 |
| 2021 | $253,962 | 44 | 7 |
| 2020 | $35,624 | 5 | 0 |
| 2019 | $6,485 | 3 | 0 |
| 2018 | $105,099 | 19 | 0 |
| 2017 | $333,062 | 66 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.9M | 1,467 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion (Pass 17) | ADMA BioManufacturing LLC | $853,568 | 7 |
| A Phase IV, Multicenter, Open-label Study to Evaluate the Safety and Pharmacokinetics of BIVIGAM in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16 | Biotest Pharmaceuticals Corporation | $229,997 | 3 |
| A Phase IV, Multicenter, Open-label Study to Evaluate the Safety and Pharmacokinetics of BIVIGAM in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16 | ADMA BioManufacturing LLC | $109,709 | 3 |
| A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion (Pass 17) | Biotest Pharmaceuticals Corporation | $103,065 | 0 |
Top Doctors Receiving Payments for Bivigam
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Fairfax, VA | $1.0M | 676 |
| , M.D | Allergy & Immunology | Saint Petersburg, FL | $194,161 | 21 |
| , MD | Infectious Disease | Wichita, KS | $170,014 | 184 |
| , M.D | Allergy & Immunology | Overland Park, KS | $104,684 | 135 |
| , M.D | Specialist | Centennial, CO | $94,261 | 146 |
| , MD | Allergy & Immunology | Brooklyn, NY | $60,884 | 67 |
| , MD, PHD | Allergy & Immunology | Dallas, TX | $44,841 | 57 |
| , MD | Pediatrics | Durham, NC | $34,121 | 3 |
| , MD | Infectious Disease | Austin, TX | $31,647 | 36 |
| , M.D | Internal Medicine | North Palm Beach, FL | $29,614 | 1 |
| , D.O | Student in an Organized Health Care Education/Training Program | Cleveland, OH | $21,960 | 26 |
| , M.D | Allergy & Immunology | Normal, IL | $21,783 | 34 |
| , MD | Internal Medicine | Macon, GA | $20,419 | 25 |
| , MD | Allergy & Immunology | Walnut Creek, CA | $15,280 | 13 |
| , MD | Allergy & Immunology | Fairfax, VA | $13,284 | 3 |
| , MD | Allergy & Immunology | Plano, TX | $13,068 | 16 |
| , MD | Allergy & Immunology | Irving, TX | $8,385 | 15 |
| , M.D | Allergy & Immunology | Oklahoma City, OK | $2,770 | 6 |
| , M.D | Rheumatology | Atlanta, CT | $50.00 | 1 |
| , M.D | Pediatric Hematology-Oncology | Fort Lee, NJ | $36.99 | 1 |
| , MD | Pediatric Critical Care Medicine | San Antonio, TX | $36.66 | 1 |
Manufacturing Companies
- ADMA BioManufacturing LLC $1.6M
- Biotest Pharmaceuticals Corporation $333,062
Product Information
- Type Drug
- Total Payments $1.9M
- Total Doctors 20
- Transactions 1,467
About Bivigam
Bivigam is a drug associated with $1.9M in payments to 20 healthcare providers, recorded across 1,467 transactions in the CMS Open Payments database. The primary manufacturer is ADMA BioManufacturing LLC.
Payment data is available from 2017 to 2023. In 2023, $606,245 was paid across 739 transactions to 14 doctors.
The most common payment nature for Bivigam is "Unspecified" ($1.9M, 100.0% of total).
Bivigam is associated with 4 research studies, including "A Multicenter, Non-interventional, Observational, Prospective Study to Assess Hypotension in Patients With Primary Immunodeficiency Disease Treated With Bivigam (Human 10%) or Other Commercial Human 10% Immune Globulin (Intravenous) (IGIV) Products During Infusion and up to 72 Hours Post Infusion (Pass 17)" ($853,568).